Cerebrospinal fluid dynamics and intracranial pressure elevation in neurological diseases
Open Access
- 10 April 2019
- journal article
- review article
- Published by Springer Science and Business Media LLC in Fluids and Barriers of the CNS
- Vol. 16 (1), 1-18
- https://doi.org/10.1186/s12987-019-0129-6
Abstract
The fine balance between the secretion, composition, volume and turnover of cerebrospinal fluid (CSF) is strictly regulated. However, during certain neurological diseases, this balance can be disrupted. A significant disruption to the normal CSF circulation can be life threatening, leading to increased intracranial pressure (ICP), and is implicated in hydrocephalus, idiopathic intracranial hypertension, brain trauma, brain tumours and stroke. Yet, the exact cellular, molecular and physiological mechanisms that contribute to altered hydrodynamic pathways in these diseases are poorly defined or hotly debated. The traditional views and concepts of CSF secretion, flow and drainage have been challenged, also due to recent findings suggesting more complex mechanisms of brain fluid dynamics than previously proposed. This review evaluates and summarises current hypotheses of CSF dynamics and presents evidence for the role of impaired CSF dynamics in elevated ICP, alongside discussion of the proteins that are potentially involved in altered CSF physiology during neurological disease. Undoubtedly CSF secretion, absorption and drainage are important aspects of brain fluid homeostasis in maintaining a stable ICP. Traditionally, pharmacological interventions or CSF drainage have been used to reduce ICP elevation due to over production of CSF. However, these drugs are used only as a temporary solution due to their undesirable side effects. Emerging evidence suggests that pharmacological targeting of aquaporins, transient receptor potential vanilloid type 4 (TRPV4), and the Na+–K+–2Cl− cotransporter (NKCC1) merit further investigation as potential targets in neurological diseases involving impaired brain fluid dynamics and elevated ICP.Keywords
Funding Information
- NSW Ministry of Health
- The University of Newcastle Faculty of Health and Medicine
This publication has 151 references indexed in Scilit:
- Aquaporins in Clinical MedicineAnnual Review of Medicine, 2012
- Temporal course of cerebrospinal fluid dynamics and amyloid accumulation in the aging rat brain from three to thirty monthsFluids and Barriers of the CNS, 2012
- Blood–brain barrier damage, but not parenchymal white blood cells, is a hallmark of seizure activityBrain Research, 2010
- Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic reviewThe Lancet Neurology, 2009
- Inhibition of Aquaporin-1 and Aquaporin-4 Water Permeability by a Derivative of the Loop Diuretic Bumetanide Acting at an Internal Pore-Occluding Binding SiteMolecular Pharmacology, 2009
- Hypoxia-inducible factor-1α signaling in aquaporin upregulation after traumatic brain injuryNeuroscience Letters, 2009
- Multiplicity of cerebrospinal fluid functions: New challenges in health and diseaseFluids and Barriers of the CNS, 2008
- Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implicationsThe Lancet Neurology, 2007
- Temporary loss of perivascular aquaporin-4 in neocortex after transient middle cerebral artery occlusion in miceProceedings of the National Academy of Sciences of the United States of America, 2006
- Aquaporins in endotheliaKidney International, 2006